ZEUS System vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Prolaio

AI Verdict

The ZEUS System specializes in the AI-powered detection and characterization of cardiac arrhythmias, such as Atrial Fibrillation, through continuous ECG monitoring from dedicated wearable biosensors. Conversely, the prolaio eVO2peak Module focuses on estimating peak oxygen consumption using a combination of demographic data, ECG, and accelerometry from third-party wearables, serving as an adjunctive tool for cardiovascular evaluation and research. While both are cloud-based Cardiology AI tools utilizing wearable data, they address distinct clinical objectives: arrhythmia diagnosis versus physiological fitness assessment.

Choose ZEUS System if…

Choose ZEUS System if your primary objective is long-term, continuous cardiac monitoring for the detection and characterization of arrhythmias, such as Atrial Fibrillation. This tool is ideal for identifying both symptomatic and asymptomatic cardiac events over an extended period, providing detailed ECG analysis and preliminary reports to aid in early diagnosis and management.

View ZEUS System →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if your focus is on assessing cardiorespiratory fitness and estimating peak oxygen consumption (eVO2peak) for cardiovascular risk stratification, rehabilitation planning, or research purposes. This software is best suited for leveraging existing compatible wearable sensor data to provide an adjunctive aid in clinical evaluation of a patient's functional capacity.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ZEUS System prolaio eVO2peak Module
Pricing Not disclosed Contact for pricing
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware. Cloud-based (software-only, processes remote sensor data)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System

The ZEUS System (Tool A) offers preliminary report generation for physicians and explicit HL7-based EHR integration, suggesting a streamlined workflow within its ecosystem. Its integration with proprietary Zio monitors provides a cohesive user experience. In contrast, prolaio eVO2peak Module (Tool B) processes data from qualified third-party sensors, which could introduce variability in the user experience depending on the specific sensor used.

Clinical Value

ZEUS System

Both tools are FDA-cleared and address significant cardiovascular needs. The ZEUS System (Tool A) directly aids in the detection and characterization of arrhythmias like Atrial Fibrillation through continuous ECG monitoring, offering immediate diagnostic value. While the prolaio eVO2peak Module (Tool B) provides valuable eVO2peak estimation as an adjunctive aid, the direct diagnostic capability of Tool A for a specific condition offers a more actionable clinical impact.

Pricing & Value

Tie

Neither tool discloses its pricing information in the provided facts. Tool A states 'not disclosed' and Tool B states 'contact for pricing,' making a direct comparison of their pricing and overall value impossible without further details.

Enterprise Readiness

ZEUS System

Both tools are cloud-based, FDA-cleared, HIPAA compliant, and have BAAs. However, the ZEUS System (Tool A) explicitly highlights 'HL7-based EHR integration' as a key feature. This direct mention of a standard for electronic health record integration gives Tool A a clear advantage in terms of readiness for seamless adoption within larger healthcare enterprise systems.

Innovation

prolaio eVO2peak Module

While both leverage AI, the prolaio eVO2peak Module (Tool B) demonstrates a more novel application by estimating peak oxygen consumption (eVO2peak) using a locked deep-learning model from diverse inputs like demographic data, single-lead ECG, and triaxial accelerometry from remote wearable sensors. This non-invasive estimation of a complex physiological parameter from real-world data represents a significant innovative leap compared to enhancing an existing cardiac monitoring paradigm.

Support & Docs

ZEUS System

iRhythm Technologies (Tool A) explicitly offers 24/7 patient support via phone and email, along with dedicated provider support. Prolaio (Tool B) indicates a 'Clinical Support & Zendesk Specialist' role to handle support requests via phone, email, and tickets, and provides a general contact email. The explicit mention of 24/7 patient support for Tool A suggests a more robust and readily available support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ZEUS System prolaio eVO2peak Module
Primary Function AI-powered software analyzing ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. FDA-cleared software to estimate peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care.
Company iRhythm Technologies Prolaio
Key Features AI-powered arrhythmia detection, continuous ECG monitoring (up to 14 days), cloud-based data analytics, detection and characterization of Atrial Fibrillation (AFib), preliminary report generation for physicians, integration with Zio Watch and Zio monitors, support for symptomatic and asymptomatic cardiac events, HL7-based EHR integration. Estimates peak oxygen consumption (eVO2peak), utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs, processes data from qualified third-party FDA-cleared wearable medical sensors, applies a locked deep-learning model for eVO2peak estimation, provides information as an adjunctive aid in clinical evaluation, enables high-density, longitudinal data collection, leverages real-world patient data and insights, features FDA-cleared software and proprietary algorithms.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Clinical Decision Support & Reference
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring ZEUS System and prolaio eVO2peak Module.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The ZEUS System is designed for long-term continuous cardiac monitoring, specifically aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. In contrast, the prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care.
The ZEUS System analyzes ECG data from wearable biosensors, integrating with Zio Watch and Zio monitors. The prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.
The ZEUS System provides AI-powered arrhythmia detection, continuous ECG monitoring data, and preliminary report generation for physicians. The prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) and offers this information as an adjunctive aid in clinical evaluation.
The ZEUS System focuses on early arrhythmia detection and management through continuous monitoring for up to 14 days. The prolaio eVO2peak Module focuses on estimating eVO2peak, which is useful for cardiovascular research and care, and enables high-density, longitudinal data collection.
The ZEUS System offers HL7-based EHR integration. The prolaio eVO2peak Module is cloud-based software that processes remote sensor data from qualified third-party FDA-cleared wearable medical sensors.
The ZEUS System provides continuous ECG monitoring for up to 14 days. The prolaio eVO2peak Module's description does not specify a maximum monitoring duration, but rather processes remote sensor data for eVO2peak estimation.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.